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CDK1-mediated phosphorylation at H2B serine 6 is
required for mitotic chromosome segregation
Markus Seibert1, Marcus Krüger2,3, Nikolaus A. Watson4, Onur Sen4, John R. Daum5, Johan A. Slotman6, Thomas Braun7,
Adriaan B. Houtsmuller6, Gary J. Gorbsky5, Ralf Jacob8, Michael Kracht9, Jonathan M.G. Higgins4, and M. Lienhard Schmitz1
Faithful mitotic chromosome segregation is required for the maintenance of genomic stability. We discovered the
phosphorylation of histone H2B at serine 6 (H2B S6ph) as a new chromatin modiﬁcation site and found that this modiﬁcation
occurs during the early mitotic phases at inner centromeres and pericentromeric heterochromatin. This modiﬁcation is
directly mediated by cyclin B1–associated CDK1, and indirectly by Aurora B, and is antagonized by PP1-mediated
dephosphorylation. H2B S6ph impairs chromatin binding of the histone chaperone SET (I2PP2A), which is important for mitotic
ﬁdelity. Injection of phosphorylation-speciﬁc H2B S6 antibodies in mitotic cells caused anaphase defects with impaired
chromosome segregation and incomplete cytokinesis. As H2B S6ph is important for faithful chromosome separation, this
modiﬁcation may contribute to the prevention chromosomal instability and aneuploidy which frequently occur in cancer cells.
Introduction
The precise temporal and spatial control of events during cell
cycle progression depends on many enzymatic activities. This is
well exempliﬁed by the process of mitosis, which is character-
ized by a widespread increase in phosphorylation site occu-
pancy, as revealed by quantitative phosphoproteomics (Olsen
et al., 2010). The spatiotemporal coordination of the mitotic
phases requires the restriction of the activity time and subcel-
lular localization of mitotic kinases and phosphatases. Mitotic
phosphorylations prominently occur on proteins controlling
metabolic processes, mitosis regulators, and on kinetochore
proteins and histones (Johnson, 2011; Funabiki andWynne, 2013;
Swaffer et al., 2016). Histone modiﬁcations help orchestrate
chromosome congression and segregation, but also may partic-
ipate in the down-regulation or reestablishment of gene ex-
pression (Wang and Higgins, 2013).
Kinases controlling mitosis include the master regulator
CDK1-cyclin B1, which phosphorylates multiple substrates, in-
cluding linker histone H1, and is indispensable for early mitotic
events (Langan et al., 1989; Domingo-Sananes et al., 2011). An-
other important mitotic kinase is Aurora B which, together with
INCENP, Borealin, and Survivin, forms the chromosomal pas-
senger complex (CPC). This complex is found at several locations
during mitosis, including centromeres, where it monitors bi-
orientation of chromosomes and is required for the correction
of spindle-kinetochore attachment errors and spindle assembly
checkpoint signaling (Carmena et al., 2012). Aurora B also
phosphorylates histones H3 and H1.4, resulting in displacement
of heterochromatin protein 1 from chromosomes in mitosis (Van
Hooser et al., 1998; Goto et al., 2002; Fischle et al., 2005; Hirota
et al., 2005; Hergeth et al., 2011). While Aurora B–mediated
histone phosphorylation occurs all along the chromosomes,
other histone phosphorylation marks show more distinct local-
ization at centromeres or pericentromeric heterochromatin. For
example, mitotic phosphorylation of H3 T3 and H3.3 S31 is en-
riched at inner centromeres, the chromatin regions between the
kinetochore-bound centromeres that are enriched in di- and
trimethylated H3 lysine 9 (H3 K9me2/3; Goto et al., 2002; Dai
et al., 2005; Hake et al., 2005; Yamagishi et al., 2010; Müller and
Almouzni, 2017).
Mitotic kinases are counterregulated by phosphatases such as
PP1 and PP2A, which occur in complexes consisting of catalytic
subunits in association with different regulatory and targeting
factors (Brautigan, 2013; Grallert et al., 2015). These phospha-
tases are also controlled by kinase signaling, as, for example,
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Aurora B and CDK1-cyclin B1 can inhibit PP1 action in early
mitosis (Liu et al., 2010; Vagnarelli et al., 2011; Qian et al., 2013,
2015; Nasa et al., 2018). The phosphatase PP2A can be negatively
regulated by the nuclear oncoprotein SET (also known as
I2PP2A), a mechanism with importance for sister chromatid
resolution (Li et al., 1996; Chambon et al., 2013; Moshkin et al.,
2013; Qi et al., 2013).
However, the SET protein has been associated with several
different functions, including a role as a component of the in-
hibitor of acetyltransferases complex (Seo et al., 2001) and a
function as a histone chaperone with the ability to bind H2B and
H3 in vitro (Muto et al., 2007; Karetsou et al., 2009). SET also
contributes to the removal of phosphorylated histone H1 and
Shugoshins from chromosomes during cell division (Krishnan
et al., 2017). Shugoshin-like (Sgo) proteins collaborate with PP2A
to prevent untimely removal of centromeric cohesin, a ring-
shaped multi-protein complex containing the Rad21 protein
that holds sister chromatids together until anaphase (Nasmyth
and Haering, 2009).
Here, we report the identiﬁcation of H2B S6 phosphorylation
as a novel histone tail modiﬁcation that occurs between pro-
phase and anaphase in mitosis and is enriched at the inner
centromeres. Its highly regulated spatial and temporal occur-
rence is controlled by an interplay between cyclin B1–associated
CDK1 activity and PP1 phosphatases. This phosphorylation
weakens the association of SET with histones and perturbation
of H2B S6ph by injection of phospho-speciﬁc antibodies impairs
the ﬁdelity of chromosome segregation.
Results
H2B S6ph occurs in early mitosis
During a search for new histone phosphorylation sites by mass
spectrometry (MS), we discovered modiﬁcation of H2B S6 by
in vitro kinase assays. The sequence context of this novel site is
conserved in vertebrates and surrounded by many further
posttranslational modiﬁcations at the N-terminal H2B tail (Fig. 1
A; Cheung et al., 2003; Beck et al., 2006; Tan et al., 2011; Cao
et al., 2013; Huang et al., 2014). Phospho-speciﬁc antibodies
against phosphorylated H2B S6 (anti-H2B S6ph) were raised,
afﬁnity puriﬁed, and tested by Western blotting. Extracts from
cells treated with the PP1/PP2A inhibitor calyculin A allowed the
detection of H2B S6ph, while no signal was detected in extracts
from untreated cells. The signal was absent in extracts that were
incubated with λ phosphatase, indicating a phosphorylation-
speciﬁc recognition of H2B S6 by antibodies (Fig. 1 B). Fur-
thermore, a phosphorylation-deﬁcient H2B S6A mutant protein
was not recognized, while a phospho-mimetic H2B S6E mutant
was detected, showing the speciﬁcity of the antibody (Fig. S1 A).
A further characterization of the antibodies by ELISA experi-
ments showed that anti-H2B S6ph antibodies speciﬁcally detect
H2B S6ph irrespective of mono-methylation or acetylation at the
adjacent K5 (Fig. S1 B).
To identify signals leading to H2B S6ph, cells were exposed to
a variety of different stimuli representing DNA damage, in-
ﬂammatory conditions, or microtubule poisons. Among these
agents, only treatment with nocodazole or taxol resulted in a
strong increase of H2B S6ph (Fig. 1 C). As nocodazole or taxol
interfere with the formation of mitotic spindles, we then tested
whether H2B S6ph occurs in mitosis.
Extracts from synchronized HeLa cells showed that H2B S6ph
occurred during mitosis and disappeared coincident with the
decay of cyclins A and B1, Aurora B, and H3 S10ph (Fig. 1 D).
Super-resolution 3D structured illumination microscopy (3D-
SIM) was used to investigate the occurrence and localization of
mitotic H2B S6ph and α-tubulin in diploid RPE-1 cells. H2B S6ph
was not detectable in interphase cells, but increased from pro-
phase to metaphase and decreased rapidly during anaphase
(Fig. 1 E). The exact timing and unidirectional mitotic progres-
sion involves the ubiquitin-/proteasome-mediated degradation
of key regulators such as Aurora B and cyclin B1 (Wieser and
Pines, 2015). To test whether ubiquitin-/proteasome-dependent
processes affect the kinetics of mitotic H2B S6ph, HeLa cells
were treated with nocodazole, and prometaphase-arrested cells
were collected by mitotic shake-off and released in the absence
or presence of the proteasome inhibitorMG132. In contrast to H3
S10 phosphorylation, H2B S6ph already strongly decreased
within 1 h. In MG132-treated cells phosphorylated H2B S6 and
H3 S10 still occurred 4 h after release, although H2B S6ph de-
clined slightly faster than H3 S10ph (Fig. 1 F).
H2B S6 phosphorylation is found on pericentromeric
heterochromatin and highly enriched at inner centromeres
Immunoﬂuorescence staining did not only reveal restriction
of H2B S6ph to early mitosis, but also showed localized
phosphorylation at distinct chromosomal regions. To inves-
tigate whether H2B S6ph occurs at centromeres, RPE-1 cells
were stained with antibodies against phosphorylated H2B S6
and the histone variant CENP-A, a marker of the centromere
(Foltz et al., 2006). Phosphorylated H2B S6 and CENP-A ex-
hibited largely nonoverlapping but proximal localization
during the various mitotic phases (Fig. 2 A) and a clear co-
localization with the CPC subunit Aurora B (Fig. 2 B), which is
known to be localized to inner centromeres until anaphase
(Wang et al., 2011).
To map the exact localization of phosphorylated H2B S6,
chromosome spreads were prepared from mitotic RPE-1 cells
and stained with antibodies against phosphorylated H2B S6 and
different proteins and chromatin markers (Fig. 2 C). Consis-
tently, the localization of H2B S6phmatched with that of Aurora
B. Phosphorylated H2B S6 showed overlapping costaining pat-
terns with H3 K9me2/3 (Fig. 2 C), a marker of pericentromeric
heterochromatin (McManus et al., 2006). Also, the quantitative
analysis of H2B S6ph and CENP-A localization revealed the
strongest enrichment of this phosphorylation at the inner cen-
tromere being between two CENP-A spots (Fig. 3 A).
During these experiments, we noted differential localization
of H2B S6ph depending on the resolution status of the chromatid
arms. Chromosomes from prophase cells, which displayed co-
hesin along the chromatids, showed a more extended H2B S6ph,
while prometaphase chromosomes showed cohesin RAD21 and
H2B S6ph only at the inner centromeres and pericentromeric
heterochromatin (Fig. 3 B), as schematically summarized in
Fig. 3 C.
Seibert et al. Journal of Cell Biology 1165
Mitotic H2B S6 phosphorylation https://doi.org/10.1083/jcb.201806057
Figure 1. Identiﬁcation of mitotic H2B S6ph. (A) The sites of the H2B N-terminal tail known to be modiﬁed by phosphorylation (ph), acetylation (ac),
methylation (me), or ubiquination (ub) are shown in black; the novel phosphorylation of S6 is marked in red. (B) 293T cells were treated with 50 nM calyculin A
for 30 min, and lysates were incubated with λ phosphatase as shown. Equal amounts of protein contained in cell lysates were analyzed byWestern blotting for
the occurrence and phosphorylation of H2B with speciﬁc antibodies. The positions of molecular weight markers are indicated. (C) HeLa cells were treated with
the indicated reagents or the DMSO vehicle control for 16 h and lysed with SDS sample buffer. Lysates were analyzed by SDS-PAGE andWestern blotting using
the indicated antibodies; the cleaved form of the caspase substrate PARP is indicated by an asterisk. (D) HeLa cells were synchronized by a double thymidine
block and released into S phase. Cells were lysed at the indicated time points with SDS sample buffer. Lysates were analyzed by SDS-PAGE and Western
blotting using the indicated antibodies. (E) Diploid RPE-1 cells were ﬁxed, and immunostaining was performed with antibodies against H2B S6ph and α-tubulin.
DNA was visualized with Hoechst 33342. Bars: 5 µm (main); 2 µm (magniﬁcation). 3D-SIM was used to reveal the occurrence and localization of the stained
proteins during the indicated mitotic phases; the boxed areas are displayed in 4× magniﬁcation. (F) HeLa cells were synchronized by treatment with no-
codazole for 16 h and released in the presence of 10 µMMG132 or DMSO. Cells were lysed at the indicated time points with SDS sample buffer and analyzed by
SDS-PAGE and Western blotting using the indicated antibodies.
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Further immunoﬂuorescence experiments were performed
to compare the phosphorylation kinetics of H2B S6 with that of
H3 S10 (Fig. 4 A) and H3 T3 (Fig. 4 B). H3 S10 phosphorylation
differed from H2B S6 modiﬁcation, as it already increased dur-
ing late G2 and decreased only in late anaphase, consistent with
published literature (Hendzel et al., 1997). Similarly, H3 T3ph
was detectable in prophase earlier than H2B S6ph and persisted
longer in anaphase (Fig. 4 B; Dai et al., 2005). The analysis of
chromosome spreads showed remarkable differences in chromo-
somal localization, as phosphorylated H3 S10 was found all along
Figure 2. Analysis of chromosomal localization of
H2B S6ph by 3D-SIM. (A) RPE-1 cells were stained for
H2B S6ph and CENP-A localization with speciﬁc anti-
bodies, DNA was revealed by Hoechst dye. Different
mitotic phases are shown. Bars: 2 µm (main); 1 µm
(magniﬁcation). (B) The experiment was done as in A,
with the difference that cells were stained for H2B S6ph
and Aurora B. The boxed areas in A and B are displayed
in 10× magniﬁcation. Bars: 2 µm (main); 1 µm (magni-
ﬁcation). (C) RPE-1 cells were arrested at G2/M transi-
tion with the CDK1 inhibitor RO 3306 for 16 h and
released into mitosis for 1 h in the presence of noco-
dazole. Chromosome spreads were produced for im-
munostaining against H2B S6ph, Aurora B, H3 K9 me2/3,
or CENP-A as shown. Pictures show chromosome
spreads of representative cells. Bars, 1 µm.
Seibert et al. Journal of Cell Biology 1167
Mitotic H2B S6 phosphorylation https://doi.org/10.1083/jcb.201806057
the chromosome arms, while H2B S6 was highly enriched at inner
centromeres (Fig. 4 C). In contrast, the chromosomal localization
of phosphorylated H3 T3 and H2B S6 showed strong overlap at the
inner centromeres (Fig. 4 D), though H3 T3ph was more visible
than H2B S6ph on chromosome arms in cell preparations that
were not subject to nocodazole arrest and spreading (Fig. 4 B).
Identiﬁcation of cyclin B1–associated CDK1 as H2B S6 kinase
To identify the H2B S6 kinase by an unbiased approach, we
performed an siRNA screen. HeLa cells were transfected with a
Dharmacon siRNA library against kinases and kinase-related
proteins. Cells were treated with nocodazole and stained with
anti-H2B S6ph antibodies and, as a control, also with anti-H3
T3ph antibodies. The known kinase Haspin was the top candi-
date for H3 T3ph, showing the functionality of this screening
approach (data not shown). High ranking candidates for H2B
S6ph were Aurora B, BubR1, and CDK1 (Fig. 5 A and Table S1). As
this screening approach can detect direct and also indirect
kinases for H2B S6ph, we performed follow up studies. Over-
expression of cyclin B1 weakly increased H2B S6ph, while co-
expression of Aurora B and INCENP strongly triggered this
modiﬁcation (Fig. 5 B). No induction of H2B S6ph was seen after
expression of the checkpoint protein BubR1 (Fig. 5 B). To test the
contribution of Aurora B, CDK1, and further mitotic kinases for
H2B S6ph by a pharmacological approach, nocodazole-arrested
HeLa cells were collected by mitotic shake-off and released in
the presence of MG132 (to preserve H2B S6ph) and different
kinase inhibitors. Phosphorylation was absent in cells treated
with the Aurora B inhibitor AZD1152 or the CDK1 inhibitor RO-
3306, while inhibition of Plk1 or Haspin did not affect H2B S6ph
(Fig. 5 C and Fig. S2).
Since both inhibitors also showed indirect effects on other
modiﬁcations (e.g., Haspin-mediated H3 T3ph), we performed
in vitro kinase experiments to test if one of the kinases can di-
rectly phosphorylate H2B S6. Aurora B was coexpressed to-
gether with INCENP in 293T cells and immunoprecipitated for
in vitro kinase assays using recombinant histone octamers as
substrate. Although Aurora B was able to phosphorylate its
known substrate, H3 S10, no phosphorylation-speciﬁc signal
could be detected for H2B S6, arguing against Aurora B as H2B
S6 kinase. In contrast, immunoprecipitated constitutively active
CDK1 (T14A/Y15F), but not kinase-inactive CDK1 (D145N), efﬁ-
ciently phosphorylated H2B S6 in histone octamers (Fig. 5 D) and
showed in vitro kinase activity toward S6 in recombinant H2B,
but not for S10 in recombinant H3 (Fig. 5 E). Furthermore, en-
dogenous cyclin B1 from mitotic HeLa cells was found to be as-
sociated with CDK1 activity leading to H2B S6 in vitro
phosphorylation (Fig. 5 F). Further in vitro kinase assays using
immunoprecipitated cyclin B1-Venus showed that coexpression
of constitutively active CDK1 augmented cyclin B1–associated
kinase activity, while the kinase-inactive CDK1 diminished this
phosphorylation (Fig. 6 A). The cyclin B1–associated in vitro
kinase activity was also diminished after inhibition of CDKswith
the small molecule inhibitor, Roscovitine (data not shown), or
the recombinant p21CIP1 protein, an inhibitor of CDK activity
(Fig. 6 B; Satyanarayana et al., 2008). To test H2B S6ph in a fully
reconstituted system, we performed in vitro phosphorylation
Figure 3. Analysis of inner centromeric H2B S6ph localization. (A)
Synchronized RPE-1 cells were used to produce chromosome spreads, which
were stained with antibodies speciﬁc for H2B S6ph (red) and CENP-A (green).
Bar, 1 µm. The images were quantitatively analyzed with ImageJ for the
distribution of H2B S6ph and CENP-A along the centromere cross section, as
shown by the dotted line (top). The maximum of ﬂuorescence intensity was
set as 1, and shaded areas indicate standard deviations (n = 8 cells/368
centromere pairs). (B) The experiment was done as in Fig. 2 C, with the
difference that chromosomes were stained for H2B S6ph and the cohesin
component RAD21. Representative examples are shown; the boxed area is
displayed in the bottom panel in 4× magniﬁcation. Bars: 5 µm (main); 1 µm
(magniﬁcation). (C) Schematic representation of the chromosomal localiza-
tion of H2B S6ph on mitotic chromatids.
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assays using recombinant and puriﬁed CDK1 together with its
cognate cyclin B1. These experiments revealed strong H2B S6
phosphorylation by CDK1-cyclin B1, while no H3 S10ph was
detected in controls (Fig. 6 C).
We then used a tethering system to investigate the contri-
bution of CDK1 and cyclin B1 for H2B S6ph in vivo, while min-
imizing indirect and confounding effects on mitosis, which can
be caused by overexpression of constitutively active CDK1
Figure 4. Comparative analysis of mitotic histone phosphorylations. (A) RPE-1 cells were stained for H2B S6ph and H3 S10ph in various phases of mitosis
with speciﬁc antibodies; DNA was revealed by Hoechst dye. Different mitotic phases are shown. Bars, 2 µm. (B) RPE-1 cells were stained for H2B S6ph, H3
T3ph, and the kinetochore marker protein CENP-C during various mitotic phases. Bars, 2 µm. (C) Chromosome spreads were produced from nocodazole-
arrested cells, which were stained for phosphorylation of H2B S6 and H3 S10. Bars, 1 µm. (D) RPE-1 cells were treated for 2 h with 2 µM nocodazole, and
chromosome spreads were produced to stain for H2B S6ph and H3 T3ph. Bars, 1 µm.
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(Szmyd et al., 2018). U2OS F4 2B8 cells containing an array of
lacO sites stably integrated close to the centromere of chromo-
some 2 (Jegou et al., 2009) were transfected to express a non-
degradable form of cyclin B1 (R42A/L45A; Va´zquez-Novelle
et al., 2014) fused with GFP and the lacO-binding lacI protein
in the absence or presence of CDK1. Expression of nondegrad-
able cyclin B1 alone caused the cell cycle–independent occur-
rence of H2B S6ph at the lacO repeats (Fig. 6 D). While
coexpression of constitutively active CDK1 augmented focal H2B
S6ph, the expression of kinase-inactive CDK1 reduced this
phosphorylation (Fig. 6 D). In summary, these different gain-of-
function and loss-of-function experiments show the direct and
prominent contribution of CDK1-cyclin B1 for H2B S6ph.
The centromeric localization of H2B S6ph is controlled by
mitotic phosphatases
The localization of the H2B S6 kinase CDK1 is not restricted to
centromeres (Pines and Hunter, 1991), suggesting that additional
mechanisms ensure the spatially deﬁned localization of H2B
S6ph. To investigate whether the localization and intensity of
H2B S6ph can be controlled by PP1/PP2A phosphatases, RPE-
1 cells were released from a RO-3306 block into medium con-
taining nocodazole and inhibitors with different speciﬁcities for
PP1 and/or PP2A. Selective inhibition of PP2A with LB-100
(Cervone et al., 2018) resulted only in a slight extension of H2B
S6ph to areas outside from the centromere, while simultaneous
inhibition of PP1 and PP2A by okadaic acid (Fig. 7 A) resulted in a
higher intensity of H2B S6ph and its spreading along the chro-
mosome arms. These results were also conﬁrmed in unsyn-
chronized cells, where okadaic acid or calyculin A caused an
increase in the intensity and localization of H2B S6ph in mitotic
cells, while selective inhibition of PP2A by LB-100 remained
without a signiﬁcant impact (Fig. S3 A). Similarly, the knock-
down of PP1 catalytic subunits with reported siRNAs (Qian et al.,
2011) worked well (Fig. S3 B) and resulted in increased intensity
and extended localization of H2B S6ph (Fig. 7 B). Aurora B
Figure 5. Analysis of H2B S6 phosphorylation
networks. (A) HeLa cells were transfected with
a Dharmacon siRNA library against kinase and
kinase-related genes. After 42 h, cells were
treated with 200 nM nocodazole for 6 h and
prepared for immunoﬂuorescence staining
against phosphorylated H2B S6. Phosphorylation
intensities were quantiﬁed using a wide ﬁeld
Nikon microscope (Eclipse Ti-E) and high-
content analysis software. Volcano plot shows
standard deviations of average scores frommean
H2B S6 phosphorylation intensity (x axis) and
their statistical signiﬁcance (P values; y axis).
Statistical analysis was performed using Graph-
Pad Prism. Aurora B, BubR1, and CDK1 are shown
in red. (B) GFP-BubR1 and cyclin B1-Venus were
expressed in 293T cells in the absence or pres-
ence of Myc-INCENP and HA-Aurora B WT or
kinase dead (KD). Cells were lysed with SDS
sample buffer and analyzed by SDS-PAGE and
Western blotting using the indicated antibodies.
(C) HeLa cells were arrested at prometaphase
with nocodazole for 16 h and released in the
presence of MG132 together with various con-
centrations of the indicated kinase inhibitors. Cells
were lysed with SDS sample buffer and further
analyzed by immunoblotting as shown. (D) Dif-
ferent plasmids encoding the indicated proteins,
including constitutively active (AF) or kinase dead
(KD) kinases, were expressed in 293T cells as
shown. Aurora Bwas immunoprecipitated with HA
antibodies and CDK1 with anti-Flag M2 afﬁnity gel
for a subsequent in vitro kinase assay with re-
combinant histone octamers as substrate. Samples
were analyzed by SDS-PAGE, CBB staining, and
immunoblotting using the indicated antibodies;
unspeciﬁc IgG bands are indicated by asterisks. (E)
Cyclin B1-Venus and Flag-tagged CDK1 formswere
coexpressed in 293T cells. Cells were lysed with
NP-40 buffer, and CDK1 was immunoprecipitated
with anti-Flag M2 afﬁnity gel for in vitro kinase
assay using H2B and H3.1 as substrate proteins.
Samples were analyzed by SDS-PAGE, CBB staining, andWestern blotting using the indicated antibodies. (F) Lysates from nocodazole-arrested HeLa cells were used
for IP of endogenous cyclin B1, followed by in vitro kinase assays to test phosphorylation of recombinant H2B. Speciﬁc antibodies were used to reveal H2B S6ph and
precipitation of cyclin B1 and the associated CDK1. The asterisk indicates the position of the light chain from the precipitating antibodies.
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regulates the activity of PP1 in mitosis (Liu et al., 2010; Nasa
et al., 2018), so it was interesting to test the effect of Aurora B on
H2B S6ph in the absence of PP1 phosphatases. In contrast to
control siRNA treatment, where Aurora B inhibition abolished
H2B S6ph, H2B S6ph was only slightly reduced by Aurora B
inhibition in PP1 knockdown cells (Fig. 7 C). In vitro phosphatase
assays showed the dephosphorylation of H2B S6 by the puriﬁed
catalytic subunit of PP1α (Fig. 7 D), thus corroborating the role of
PP1 as a H2B S6 phosphatase. Collectively, these data raise the
possibility that Aurora B contributes to the restriction of PP1
activity to indirectly control the phosphorylation of H2B S6.
H2B S6ph is required for mitotic chromosome segregation
For the investigations on the function of H2B S6ph, we did not
interfere with CDK1-cyclin B1 activity, as the inhibition would
necessarily affect the process of mitosis as such andmodiﬁcation
of many substrates. To explore the speciﬁc role of H2B S6ph,
phosphorylation-speciﬁc H2B S6 antibodies were injected into
LLC-PK pig kidney cells, which are speciﬁcally suited for anti-
body injection assays. These cells also show mitotic H2B S6ph
similar to human cells (data not shown). After antibody injection
in prophase, progression of mitosis was followed by live cell
imaging until telophase. Control injections with rabbit IgGs did
not cause any mitotic abnormalities (Fig. 8 A; Fig. S4 A; and
Video 1). Injection of antibodies recognizing H2B S6ph did not
cause signiﬁcant differences in mitotic progression between
nuclear envelope breakdown and anaphase onset (Fig. S4 B), but
caused chromosome segregation defects with various severities,
according to the phenotypes described in Fig. S4 C. Injected cells
progressed normally through mitosis until metaphase without
defects in chromosome alignment (Fig. 8 B; Fig. S4 D; and Video
2). During anaphase, chromosome segregation appeared unco-
ordinated and slower than controls. Formation and ingression of
the cleavage furrow started at the usual time, but before com-
plete chromatid separation. Some chromosomes formed bridges
or were trapped in the cleavage furrow, a feature known as a cell
Figure 6. Identiﬁcation of CDK1 as a direct H2B S6 kinase. (A) Flag-tagged CDK1 forms were expressed with cyclin B1-Venus in 293T cells. CDK1 was
immunoprecipitated with anti-Flag M2 afﬁnity gel and cyclin B1 with GFP-Trap beads for a subsequent in vitro kinase assay with recombinant H2B. Samples
were analyzed by SDS-PAGE and immunoblotting using the indicated antibodies. (B) 293T cells were transfected to express cyclin B1-Venus or GFP as shown.
Cells were lysed with NP-40 buffer and GFP, and cyclin B1-Venus were immunoprecipitated with the GFP-Trap for a subsequent in vitro kinase assay using
recombinant H2B as a substrate protein. The reactions were incubated in the presence or absence of 1 µg recombinant p21CIP1 protein (Sigma) as shown, H2B
S6ph was analyzed by immunoblotting. (C) 1 µg of recombinant and puriﬁed CDK1-cyclin B1 (Thermo Fisher) or 2 µg GST control (Sigma) were incubated with
recombinant H2B (2 µg) in the presence of ATP. The reaction was analyzed for histone phosphorylation byWestern blotting (top) and protein integrity by SDS-
PAGE and CBB staining. (D) U2OS F4 2B8 cells with an array of lacO sites integrated close to the centromere of chromosome 2 were transfected with GFP-lacI
alone or a nondegradable form of cyclin B1 (cyclin ND) fused to GFP-lacI and Flag-tagged forms of CDK1 AF and CDK1 KD. After 24 h, cells expressing moderate
amounts of the GFP-lacI fusion proteins were ﬁxed for immunoﬂuorescence and analyzed for phosphorylation of H2B S6 and the H3 S10 control as well as for
Flag-CDK1 localization. The left part shows representative results from the immunoﬂuorescence studies. The right part displays the ratio of cells showing
colocalization of GFP-lacI-cyclin B1 and H2B S6ph, Flag-CDK1, or H3 S10ph stained with the indicated antibodies. n > 100 cells from two independent ex-
periments were analyzed for each condition; error bars show standard deviations between the two biological replicates. Bars, 5 µm.
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untimely torn (CUT) phenotype (Hirano et al., 1986). In the most
severe case, chromosomes did not move and were forced into
one daughter cell without separating (Fig. S4 C). Quantiﬁcation
of the chromosome movements during anaphase conﬁrmed that
segregation rates were indeed decreased after anti-H2B S6ph
injection, compared with controls. The decline in chromosome
movement rates correlated with the severity of the phenotype
(Fig. 8, B and C). The average rates of chromosome movement
were comparable after PBS and rabbit IgG injection, but signif-
icantly reduced to about half of the speed after anti-H2B S6ph
injection (Fig. 8 D). This phenotype is markedly distinct from
that of the anti–phospho-H3 T3 antibodies, which delocalize
Aurora B from mitotic centromeres (Wang et al., 2010), or
anti–phospho-H3.3 S31 antibodies, which abrogate the p53 re-
sponse to chromosome missegregation (Hinchcliffe et al., 2016).
H2B S6ph lowers binding of SET to chromatin
To investigate whether protein–protein interactions can be
regulated by H2B S6ph, we performed in vitro pulldown assays
using biotinylated peptides encompassing the ﬁrst 20 amino
acids of H2B. Peptides were either unmodiﬁed or phosphory-
lated at S6 or comodiﬁed with acetylated or mono-methylated
K5. Pulldown experiments were performed using native extracts
from nocodazole-arrested HeLa cells, and bound proteins were
analyzed by SDS-PAGE and silver staining (Fig. 9 A). Two pro-
tein populations in molecular weight range between 35 and 45
kD were found to interact preferentially with unmodiﬁed H2B,
whereas phosphorylation of S6 led to an enrichment of proteins
of sizes between 25 and 35 kD. Phosphorylation-dependent in-
teractions were signiﬁcantly diminished by H2B K5 acetylation.
To identify the phosphorylation-dependent interactors, samples
were analyzed by MS (Table S2). Label-free quantiﬁcation of
bound proteins revealed binding of 14-3-3 proteins to phos-
phorylated peptides. In contrast, S6 phosphorylation diminished
binding of the SET protein. Western blot analysis with SET and
14-3-3 antibodies conﬁrmed the phosphorylation-dependent
interactions with H2B peptides (Fig. 9 B). Two isoforms of SET
(SETα and SETβ) were detected to bind preferentially to the
Figure 7. Identiﬁcation of H2B S6ph phosphatases. (A) RPE-1 cells were arrested for 16 h with RO-3306 and then released for 1 h in the presence of
nocodazole and okadaic acid (1 µM), LB-100 (10 µM), or DMSO (control) for 1 h. Chromosome spreads were analyzed by immunoﬂuorescence for H2B S6ph and
CENP-A localization. Bars: 1 µm (magniﬁcation); 5 µm (main). (B) Cells were transfected with siRNAs targeting catalytic subunits of PP1α, β, and γ or control
siRNAs (Origene). Knockdown efﬁciency was conﬁrmed by qPRC (see Fig. S3 B). After 24 h, cells were arrested at G1/S by a thymidine block and released,
followed by the addition of nocodazole for 6.5 h. The mitotic cells were further treated for 30 min with AZD1152 or the DMSO control and stained as shown.
Bars, 2 µm. (C) The experiment was performed as in B, and ﬂuorescence intensities (given in artitrary units; A.U.) were quantiﬁed from 10 representative cells
per condition using ImageJ and GraphPad Prism. (D) The recombinant H2B protein was phosphorylated by an in vitro kinase assay as described for Fig. 6 A.
CDK1-cyclin B1 was removed from the extracts by immuno-depletion and the supernatant containing 2 µg of phosphorylated H2B protein was taken and
incubated with 0.2 µg of recombinant PP1α (Novus Biologicals) or GST control (Sigma) for 30 min at 37°C. The reaction was analyzed for histone phos-
phorylation by Western blotting (top) and protein integrity by SDS-PAGE and CBB staining as shown.
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unmodiﬁed H2B tail, whereas interaction with 14-3-3 proteins
was limited to the phosphorylated peptides.
The 14-3-3 protein family is involved in many cellular func-
tions and cell cycle regulation (Gardino and Yaffe, 2011; Sawicka
and Seiser, 2014; Sluchanko and Gusev, 2017). We did not detect
14-3-3 proteins in the chromatin fraction containing H2B S6ph
(data not shown) and could not detect 14-3-3 proteins on mitotic
chromosomes in colocalization with CENP-A or H3 S10ph (Fig.
S5 A), arguing against the in vivo relevance of 14-3-3 protein
binding to H2B S6ph, at least during mitosis. To test the inter-
action of H2B and SET, GFP-tagged H2B and phosphorylation-
deﬁcient or phospho-mimetic mutants thereof were expressed
in 293T cells and immunoprecipitated from lysates after soni-
cation and benzonase treatment to allow extraction of H2B-GFP
from nucleosomes (Fig. 9 C). Binding of endogenous SET was
detected for H2B-GFP andH2B S6A-GFP, while the S6Emutation
drastically reduced interaction with SET. To test whether this
interaction is direct, we examined the binding between re-
combinant and puriﬁed full-length SET and H2B (amino acids
1–35) fused to GST. H2B-GST and its phosphorylation-defective
and phospho-mimicking mutants and His-tagged SET were
expressed and puriﬁed from Escherichia coli, and the interac-
tion was tested by GST pulldown assays. These experiments
showed direct interaction between the proteins, which was
reduced for the phospho-mimicking H2B variant (Fig. 9 D).
Co-immunoprecipitation (IP) experiments showed the neces-
sity of the C-terminal acidic domain of SET for interaction with
endogenous H2B in extracts from 293T cells (Fig. 9 E), as pre-
viously shown for SET binding to other histones (Seo et al.,
2001; Kim et al., 2012).
To determine the degree of colocalization between SET and
H2B S6ph during mitosis in the absence of a suitable antibody
faithfully detecting endogenous SET, we determined SET local-
ization by scalable expression of GFP-SET in a SET CRISPR-Cas9
knockout background (Krishnan et al., 2017) to avoid over-
expression artifacts (Fig. S5 B). This analysis showed the relo-
cation of SET from the nucleus of interphase cells to inner
centromeres and the nonchromatin fraction during early mito-
sis, as previously reported (Lam et al., 2012; Krishnan et al.,
2017). GFP-SET and H2B S6ph displayed adjacent and also par-
tially overlapping localizations at centromeres during promet-
aphase and metaphase, and GFP-SET was largely absent from
chromosomes in anaphase (Fig. 9 F).
We also used the GFP-SET expressing cells to compare the
localization of SET and CENP-A between prometaphase and
metaphase cells (Fig. 10 A). While prometaphase cells showed
Figure 8. Identiﬁcation of mitotic H2B S6ph
functions. (A) Prophase LLC-PK cells were injected
with anti-H2B S6ph antibodies or rabbit IgG at the
onset of mitosis and further traced by live cell
imaging. Pictures show representative phenotypes
after injection of rabbit IgG (top) or anti-H2B S6ph
antibodies (bottom). Time points after injection of
antibodies are indicated (min:s), areas of micro-
injections are marked with asterisks (*) and the po-
sition of the cleavage furrows by arrows. Bars,
10 µm. (B) Prophase LLC-PK cells were micro-
injected with PBS (n = 5), rabbit IgG (n = 8), or anti-
H2B S6ph antibodies (n = 6). Movement rates
(changes in µm/min) during anaphase are displayed.
Time lapse images aftermicroinjection of antibody or
PBS were collected at 1-min intervals. Chromosome
movement rates just before and during anaphase
were quantiﬁed bymeasuring the change in distance
between leading edges of the chromosome masses
as they moved poleward. Each line represents the
chromosome movement rates obtained from indi-
vidual cells. Each cell’s data were aligned so that
minute “1” represents the ﬁrst minute where ana-
phase movements were observed. (C) Chromosome
movement rates during anaphase (t = 1 min through
t = 11 min) were compared between samples from
individual anti-H2B S6ph injections. Samples were
labeled and arranged according to their phenotypes
(ranging from slight to severe chromosome seg-
regation defects). Lines show mean movement
rates and standard deviations between the time
points. (D) Average chromosome movement rates
for every time point during anaphase (t = 1 min
through t = 11 min) were calculated and compared
between the three conditions using GraphPad
Prism. Lines show mean movement rates and
standard deviations between the time points. The
asterisk (*) indicates a signiﬁcant P value < 0.04;
ns = not signiﬁcant (paired t test).
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SET mainly between the centromeres, metaphase cells showed
largely cytosolic SET with the remaining chromatin-bound SET
at centromeres. Direct costaining between SET and H2B S6ph in
metaphase cells conﬁrmed the localization of H2B S6ph at the
inner centromere, while most of the SET protein was found in
the adjacent centromere regions (Fig. 10 A). These data suggest
that colocalization between SET and H2B S6ph is still possible
during prometaphase, but largely absent during metaphase
when this phosphorylation has reached its maximum and
highest local density.
Discussion
Here, we identify H2B S6 as a novel histone phosphorylation site
that is conserved among vertebrates. The N-terminal domain of
human H2B contains many different modiﬁcation sites, and
future studies must reveal whether H2B S6ph has an impact on
any of the neighboring modiﬁcations or vice versa. We did not
detect signiﬁcant amounts of H2B S6ph during interphase or in
response to various agents causing cell stress, but this does not
exclude the possibility that H2B S6ph can be triggered in re-
sponse to further, yet unknown cues. The spatiotemporal oc-
currence of H2B S6ph is tightly regulated. During early mitosis,
this modiﬁcation is found at the inter-chromatid axis, while
prometaphase chromosomes show this modiﬁcation almost ex-
clusively at inner centromeres.
H2B S6ph occurs coincident with chromosome condensation
and spindle formation during early mitotic phases. These time
points are characterized by ongoing CDK1-cyclin B1 and Aurora
B activity, and accordingly, these kinase activities are required
for H2B S6ph. H2B S6ph colocalizes with Aurora B at inner
centromeres, where Aurora B contributes to the control of
timing and distribution of H2B S6ph, though the used mecha-
nisms are likely to be indirect and must be elucidated in the
Figure 9. Identiﬁcation of proteins showing S6ph-
dependent H2B binding. (A) HeLa cells were arrested
in mitosis with nocodazole for 16 h and lysed with NP-
40 buffer. The indicated biotin-coupled peptides with
unmodiﬁed or modiﬁed amino acids encompassing the
ﬁrst 20 amino acids from H2B were used for pulldown
assays using StrepTactin beads (Qiagen). One fraction of
the eluates was analyzed by SDS-PAGE and silver
staining. Arrows indicate phosphorylation-dependent
interactors. (B) Samples from peptide pulldown ex-
periments were analyzed by SDS-PAGE and Western
blotting using SET and 14-3-3 antibodies; arrows show
the SET and 14-3-3 isoforms. (C) GFP-tagged H2BWT or
S6 phosphorylation site mutants were expressed in
293T cells. Cells were lysed with NP-40 buffer, soni-
cated, and treated with Benzonase (Millipore). H2B-GFP
was immunoprecipitated using the GFP-Trap and SET
binding was analyzed by immunoblotting. (D) (His)6-
tagged SET (His-SET) and the indicated H2B-GST fusion
proteins were puriﬁed from E. coli BL21 and then mixed
as shown. Following incubation for 2 h of 1 µg GST fu-
sion proteins or 5 µg GST and 0.5 µg his-SET, a GST
pulldown was performed and the proteins were de-
tected by CBB staining and immunoblotting as shown.
(E) 293T cells were transfected to express GFP, GFP-
SET, or GFP-SETΔC which lacks the 59 C-terminal amino
acids. The experiment was further performed as in C,
with the exception that endogenous H2B was detected
by antibodies. (F) SET expression was eliminated in
HCT116 cells by CRISPR-Cas9–mediated gene deletion,
and a tet-inducible GFP-SET expression plasmid was
stably introduced by puromycin selection. Following
induction of GFP-SET expression by 1 µg/ml doxycycline
for 24 h, cells were arrested with RO-3306 for 16 h and
released into mitosis. Cells were stained against H2B
S6ph, and the localization of H2B S6ph and GFP-SET in
different mitotic phases is displayed. Bars, 2 µm.
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future. One possibility would be an indirect Aurora B–mediated
control on downstream H2B S6 kinases such as CDK1, while
another option is the Aurora B–dependent restriction of PP1
activity, as revealed in this study. This ﬁnding ﬁts previous re-
ports showing that Aurora B opposes PP1 function in mitosis by
phosphorylating PP1-targeting proteins (Liu et al., 2010; Qian
et al., 2013; Nasa et al., 2018). The direct phosphorylation ap-
pears to be performed by cyclin B1–associated CDK1, although
we cannot exclude the participation of further kinases. CDK1 is
known to be activated by cyclin B, but also by association with
cyclin A (Katsuno et al., 2009), a cyclin that also associates with
CDK2 to allow regulation of S phase and mitotic centrosome
doubling (Tsai et al., 1993; Hinchcliffe and Sluder, 2002). We
tested the ability of cyclin A–associated CDK1 and CDK2 for their
ability to phosphorylate H2B S6 by in vitro kinase assays (Fig. S5
C). These assays showed that cyclin A2–associated CDK1 was
capable of phosphorylating H2B S6, while CDK2 showed a re-
duced ability to phosphorylate H2B S6. Together, all experi-
ments point to a crucial role of cyclin B1–associated CDK1 for
mitotic H2B S6ph, but a possible contribution of further CDK1-
associated cyclins or even other CDKs need to be investigated in
future studies. A previous study showed that CDK substrates
lacking the classical (S/T)-P motifs are speciﬁcally dependent on
the presence of C-terminal R/K residues, and phosphorylation is
enhanced by N-terminal P residues (Suzuki et al., 2015), which
matches with the sequence of the H2B tail (see Fig. 1 A). Further
Figure 10. Spatial distribution of H2B S6ph and SET during
mitosis. (A) The HCT116 cells described in Fig. 9 (F) were in-
duced to trigger GFP-SET expression by the addition of 1 µg/ml
doxycycline for 24 h. The top and middle panels show repre-
sentative examples for ﬁxed cells that were analyzed by con-
focal microscopy for the distribution of GFP-SET and CENP-A in
prometaphase and metaphase cells. Line scan analysis was
performed for 24 centromere pairs from three different pro-
metaphase and metaphase cells, respectively. Quantiﬁcation
was done using ImageJ and GraphPad Prism; the maximum of
ﬂuorescence intensity was set as 1, and the dotted lines indicate
standard deviations. The bottom panel shows the comparison of
H2B S6ph and GFP-SET distribution in metaphase cells; line
scan analysis was done by quantitative evaluation of 48 cen-
tromere pairs from 12 different cells. Bars, 2 µm. (B) Schematic
summary depicting the possible molecular mechanisms leading
to spatial and temporal control of H2B S6ph. Mitotic chromo-
somes are shown in blue, and the position of phosphorylated
H2B is indicated in red, CENP-A chromatin in yellow, and ki-
netochores in dark green. Black arrows represent kinase activity
of CDK1-cyclin B1 and Aurora B as part of the CPC.
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support for H2B S6 being a CDK substrate comes from the notion
that this sequence is P-rich and lacks any secondary structure, in
line with the preferences of CDK substrate regions to be highly
unstructured (Moses et al., 2007).
The decay in H2B S6ph seen after metaphase-to-anaphase
transition likely results from the differential activities of CDK1-
cyclin B1, Aurora B, and PP1. Cyclin B1 is rapidly degraded at
anaphase, and Aurora B transitions from chromosome arms and
inner centromeres in early mitosis to midzone spindle micro-
tubules at anaphase (Carmena et al., 2012). Conceivably, H2B S6
phosphorylation could also be controlled by SET, which was
identiﬁed as an interactor of cyclin B1 and a CDK1 inhibitor
(Canela et al., 2003), raising the possibility that SET also con-
tributes to a negative feedback loop antagonizing H2B S6 kinase
activity. Furthermore, diminished H2B S6 phosphorylation
could also be caused by changes in the localization of these
regulators during sister chromatid separation and chromosome
segregation. In early mitosis, CDK1-cyclin B1 and Aurora B
phosphorylate substrates along chromosomes such as cohesin
regulator Sororin to release cohesin from chromosome arms
(Nishiyama et al., 2013). Cyclin B1 also localizes to unattached
kinetochores (Bentley et al., 2007; Chen et al., 2008). Consis-
tently, we observe H2B S6ph enriched at inner centromeres on
chromosomes from prometaphase cells. The spatial regulation of
H2B S6ph also involves a process of active dephosphorylation by
PP1 phosphatases. Transition of Aurora B from inner centromeres
to spindle microtubules during chromosome segregation (Goto
et al., 2006) could thus enable H2B S6 dephosphorylation by PP1
in the absence of CDK1 and Aurora B activity.
As schematically depicted in Fig. 10 B, PP1 phosphatase ac-
tivity could efﬁciently eliminate H2B S6ph at regions with low
de novo phosphorylation. High CDK1 directly phosphorylates
H2B S6 and Aurora B activity opposes phosphatase activity at
centromeres to generate H2B S6ph. Focal H2B S6ph requires not
only the delicate balance between phosphorylating and de-
phosphorylating activities, but may also depend on the coordi-
nated progression of chromosome condensation and sister
chromatid separation.
We suggest that chromatin association of SET may be con-
trolled by various mechanisms. One mechanism would involve
competition between available binding sites and repelling
modiﬁcations. The histone-binding afﬁnity of SET is lowered by
phosphorylation of H2B S6, as revealed in this study, but also by
phosphorylation of H3 at T3, S10, T11, or S28 (Schneider et al.,
2004; Kim et al., 2012). Of note, phosphorylation of H2B S6 and
H3 T3 are both found at inner centromeres, and together, these
modiﬁcations may locally accumulate sufﬁcient negative charge
to reduce the binding afﬁnity of the negatively charged
C-terminal region of SET, which mediates the contact to H2B. It
is plausible that an increase in number and local density of
phosphorylations will decrease the chromatin afﬁnity of SET,
thus enabling these phosphorylations to function as a scalable
afﬁnity regulator rather than functioning as a switch-like toggle.
It is also possible that, rather than displacing SET from
chromatin, core histone phosphorylation acts to prevent the
histone chaperone activity of SET at centromeres. Indeed, SET
localization can also be determined by its binding partner
Shugoshin, which moves from the inner centromere to kineto-
chores between prometaphase and metaphase (Liu et al., 2013).
Future studies have to reveal the relative contribution of these
different mechanisms mediating the progressive eviction of SET
from the chromatin between prometaphase and metaphase.
How can H2B S6ph inﬂuence chromosome segregation? Sis-
ter chromatids areﬁrst resolved at the chromosome arms during
prophase, while centromeric cohesion is maintained until met-
aphase. A recent study suggests that SET serves to evict phos-
phorylated linker histone H1 (H1 T18ph) and the cohesin
protector Shugoshin from chromatin to allow sister chromatid
separation and chromosome segregation in mitosis (Krishnan
et al., 2017). The need to control the activity and localization of
SET is also illustrated by the ﬁnding that its overexpression can
cause a premature loss of sister chromatid cohesion in mouse
oocytes (Qi et al., 2013) and SET depletion interferes with mei-
otic chromosome segregation (Chambon et al., 2013). We spec-
ulate that H2B S6ph (and perhaps H3 phosphorylation) impairs
the function of SET during mitosis to preserve cohesion at inner
centromeres until anaphase. Interestingly, RPE-1 cells lacking
SET exhibit a mitotic phenotype similar to cells injected with
phosphorylation-speciﬁc H2B S6 antibodies, displaying chro-
mosome missegregation and chromosome trapped in cleavage
furrows (Krishnan et al., 2017). The function of H2B S6ph for the
regulation of mitosis might not be restricted to the limitation of
SET binding and involve further mechanisms to be elucidated in
future studies.
Materials and methods
Antibodies, plasmids, and reagents
All the information on antibodies, plasmids, and reagents is
given in Table S3.
siRNA screen
Hela cells were grown in 384-well clear-bottomed plates and
treated with a siRNA kinome library (Dharmacon). Cells were
then accumulated in mitosis with 200 nM nocodazole and im-
munoﬂuorescently stained using H2B S6ph and H3 T3ph (16B2)
antibodies. Average ﬂuorescence intensity (integrated) for mi-
totic cells (deﬁned as cells positive in either H2B S6ph or H3
T3ph) was measured using a wide-ﬁeld Nikon microscope
(Eclipse Ti-E) equipped with high-content analysis software.
Excel was used to calculate the standard score for each repeat
(n = 4), and P values were calculated using one-sample t test for
each treatment. (∼300 cells measured for each treatment.)
Staining for both H2B S6ph and H3 T3ph meant that each could
serve as an internal control for the other.
Generation of phospho-speciﬁc antibodies
Anti-H2B S6ph antibodies were generated by immunization of
two rabbits with peptide SP120160 (Table S3) by PolyPeptide
Laboratories. Phosphorylation-speciﬁc antibodies were afﬁnity
puriﬁed from sera (large and ﬁnal bleedings), using peptides
C-PEPAK (for removal of unspeciﬁc antibodies; Table S3) and
SP120160 (for collection of phosphorylation-speciﬁc antibodies)
by Peptide Specialty Laboratories and Eurogentec.
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MS
Samples for MS analysis were prepared with LDS sample buffer
(2× NuPAGE LDS Sample Buffer and 2× NuPAGE Sample Re-
ducing Agent in MilliQ water) and SDS-PAGE. Gels were stained
with Coomassie brilliant blue (CBB) and cut into small pieces.
Gel pieces were washed twice with 50% (vol/vol) ethanol in ABC
buffer (50 mM ammonium bicarbonate) and dehydrated with
100% (vol/vol) ethanol. Proteins were reduced with 10 mM DTT
at 56°C for 45 min and alkylated with 55 mM iodacetamide at
room temperature for 30 min. Gel pieces were repeatedly
washed with ABC buffer and dehydrated with 100% (vol/vol)
ethanol. Proteins were digested with 48 ng Trypsin in ABC
buffer at 37°C for 16 h. Peptides were extracted with 30% (vol/
vol) acetonitrile and 3% (vol/vol) triﬂuoroacetic acid (TFA).
Extraction was repeated with 70 and 100% (vol/vol) acetonitrile.
Extracts of each gel piece were combined and mixed with one
volume buffer C (5% [vol/vol] acetonitrile and 1% [vol/vol] TFA).
StageTips were prepared with two layers of C18 resin and
washed with methanol, buffer B (80% [vol/vol] acetonitrile and
0.5% [vol/vol] acetic acid) and twice with buffer A (0.5% [vol/
vol] acetic acid in MilliQ water). Extracts were loaded on one
StageTip per gel piece. StageTips were again washed with buffer
A and stored for MS analysis at 4°C.
MS analysis was performed with an LTQ-orbitrap Velos in-
strument (Thermo Fisher) equipped with a nanoelectrospray
source (Proxeon). The mass spectrometer was operated in the
data dependent mode to monitor MS and MS/MS spectra. Sur-
vey full-scanMS spectra (fromm/z 300 to 2,000) were acquired
in the Orbitrap with a resolution of R = 60,000 at m/z 400 after
accumulation of one million ions. The ﬁve most intense ions
from the preview survey scan delivered by the Orbitrap were
sequenced by collision-induced dissociation in the LTQ. For
higher C-trap dissociation with a LTQ-Orbitrap Velos instru-
ment, 30,000 ions were accumulated in the C-trap and MS/MS
spectra were detected in the Orbitrap at a resolution of 7,500
(Olsen et al., 2010). Mass spectra were analyzed using Max-
Quant software (Version 1.0.14.10) and automated database
searching (Matrix Science; Version 2.2; Cox andMann, 2008). A
human UniProt (2015) database with common contaminants was
used for peptide and protein identiﬁcation. A false discovery
rate of 1% was used for both the peptide spectrum matches and
protein level matches with the implemented target decoy algo-
rithm. The required false positive rate was set to 1% at the
protein level, and maximum allowed mass deviation was set to 5
ppm in MS mode and 0.5 D for MS/MS peaks. Cysteine carba-
midomethylation was searched as a ﬁxed modiﬁcation, and
N-acetyl protein, oxidized methionine, and acetylation of lysine
was searched as variable modiﬁcations. A maximum of three
missed cleavages were allowed.
Cell culture and transfections
Human embryonic kidney 293 T cells, HCT116, HeLa, and RPE-
1 cells were grown in DMEM or DMEM/F12 (RPE-1) containing
10% FCS and 1% (vol/vol) penicillin/streptomycin at 37°C and 5%
CO2. Cells were seeded in dishes and transfected using the
transfection reagents Rotifect (Roth), Lipofectamine 3000 (In-
vitrogen), or linear polyethylenimine. After pipetting up and
down several times, complex formation occurred in serum- and
antibiotic-free DMEMduring 30min at room temperature. After
adding the transfection mixture to antibiotic-free DMEM con-
taining FCS, the cells were incubated 4 h before the mediumwas
changed and the cells were further grown.
Cell lysis
To prepare cell extracts under native conditions, the cells were
washed once with 1× PBS, harvested by scraping, and collected
by centrifugation for 4 min at 350 g. The pellet was resuspended
in an appropriate amount of NP-40 buffer (20 mM Tris/HCl, pH
7.5, 150 mM NaCl, 1 mM phenylmethylsulfonylﬂuoride, 10 mM
NaF, 0.5 mM sodium orthovanadate, leupeptine [10 µg/ml],
aprotinin [10 µg/ml], 1% NP-40, and 10% glycerol) and incubated
on ice for 20 min. The lysate was cleared by centrifugation for
10 min at 16,000 g. The supernatant was then used for IP ex-
periments or mixed with 5× SDS sample buffer, boiled at 95°C
for 5 min, and analyzed by Western blotting. Alternatively, cells
were directly lysed in 1× SDS sample buffer, soniﬁed to shear the
genomic DNA, and used for Western blotting.
Cell cycle synchronization
For interphase synchronization, cells were treated with com-
plete medium containing 2 mM thymidine for 16 h (ﬁrst thy-
midine block). Cells were then washed three times with warm
PBS and released in medium without thymidine for 8 h. Syn-
chronization was completed by a second thymidine block for 16
h. After three times of washing, cells were released into S phase.
Mitotic synchronization was performed either by CDK1 inhibi-
tion (RO-3306) or by mitotic spindle disruption (nocodazole and
taxol). Treatment for 16 h with 10 µM RO-3306 caused cell cycle
arrest at the G2/M transition. Cells were washed three times
with warm PBS and released into M phase. For mitotic arrest in
prometaphase, cells were treated with 0.1 µg/ml nocodazole or
100 nM taxol for 8–16 h.Mitotic cells were collected by shake-off
and released with freshmedium or kept inmitosis by addition of
10 µM MG132.
Immunoﬂuorescence staining
Cells were grown on coverslips in 12-well plates. Attached cells
were washed with PBS and ﬁxed with 4% (vol/vol) parafor-
maldehyde at room temperature for 5 min. After having been
washed for three times with PBS, cell membranes were per-
meabilized with 0.5% (vol/vol) Triton X-100, and unspeciﬁc
antibody binding was blocked with blocking solution (PBS
containing 10% [vol/vol] goat serum and 0.5% [vol/vol] Triton
X-100) at room temperature for 1 h. Cells were incubated with
primary antibody solutions (PBS containing 1% [vol/vol] goat
serum and 0.5% [vol/vol] Triton X-100) at 4°C for 16 h. Cells
werewashed three times with PBS and incubated with secondary
antibodies for 1 h at room temperature. The secondary antibodies
conjugated to Alexa Fluor 488, 594, and 647 or Cy3 were pur-
chased from Dianova and Invitrogen Molecular Probes. After
incubation, cells were washed three times, and DNA was stained
with 1 µg/ml Hoechst 33342. Coverslips were washed again and
mounted on microscope slides with Mowiol mounting medium.
Slides were stored at 4°C while being protected from light.
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Preparation of mitotic chromosome spreads
Cells were grown on coverslips, and mitotic cells were arrested
with nocodazole for 1–6 h. After medium removal, hypotonic
buffer (0.8% [wt/vol] sodium citrate/H2O; freshly added: 10 mM
NaF; 0.5 mM Na3VO4; 2 µg/ml aprotinin, 1 µg/ml leupeptin; and
1 mM PMSF) was added drop-wise, and cells were swollen for
15 min at room temperature. Cells were centrifuged on cover-
slips with a CytoSpin (Thermo Fisher) at 250 g for 5 min and
processed for immunoﬂuorescence staining.
Microinjections
LLC-PK pig kidney cells were plated on 25-mm round coverslips
and cultured to a density of ∼70%. Before microinjection, the
coverslips were mounted in stainless steel chambers with Lei-
bovitz’s L-15 medium supplemented with 10% FBS and 1% pen-
icillin and streptomycin and overlaid with light mineral oil
(Sigma) to prevent evaporation.Mitotic cells were injected using
a Burleigh micromanipulator and microneedles containing
2 mg/ml anti-H2B S6ph antibodies or, for control injections,
nonspeciﬁc rabbit IgG. Time-lapse phase contrast and ﬂuores-
cence images were collected at 37°C using a 100×/1.4 NA oil
objective and an inverted microscope (AxioObserver Z1; Zeiss),
equipped with a stage heater, air curtain, an ORCA-Flash4.0LT
camera (Hamamatsu), and Slidebook software (Intelligent
Imaging Innovations, Inc.). During microinjection, images were
collected every 170 ms and thereafter at 1 min intervals. Indi-
vidual cells were evaluated for mitotic progression, and image
panels and videos were assembled using MetaMorph software
(Molecular Devices). Distance measurements were performed
using the Metamorph’s caliper tool.
In vitro kinase and phosphatase assays
In vitro kinase assays were performed with immunoprecipitated
kinases or recombinant proteins. Cells were lysed under native
conditions and kinases were puriﬁed by IPs. Beads were washed
three times with NP-40 IP buffer and twice with kinase buffer
(60 mM Hepes, pH 7.5, 3 mM MgCl2, 3 mM MnCl2, and 1.2 mM
DTT). Supernatants were removed completely from beads
and 30 µl of kinase reaction mix (6 mM Hepes, pH 7.5, 3 mM
MgCl2, 3 mM MnCl2, 1.2 mM DTT, 10 mM NaF, 10 mM
β-glycerophosphate, 1 mM Na3VO4, 5% [vol/vol] glycerol,
20 µM ATP, and 2 µg substrate protein) was added. Samples
were incubated at 37°C for 30 min and the reaction was stopped
by addition of SDS sample buffer. After heating at 95°C for
5 min, samples were centrifuged (16,000 g; 2 min), and super-
natants were analyzed by SDS-PAGE and Western blotting. In
vitro phosphatase assays were performed by incubation of 0.2
µg PP1α (Novus Biologicals) with 2 µg phosphorylated H2B S6
using kinase buffer lacking ATP and the phosphatase inhibitors
NaF, β-glycerophosphate, and Na3VO4 for 30 min at 37°C.
IP
Proteins from a cell lysate were precipitated with antibodies
bound to protein A/G sepharose beads (Millipore) or with GFP-
Trap beads (Chromotek) or anti-Flag M2 afﬁnity gel (Sigma).
Native buffer conditions (NP40 buffer: 20 mM Tris/HCl, pH 7.5,
150 mMNaCl, 1% [vol/vol] NP-40, 10% [vol/vol] glycerol, 10 mM
NaF, and 0.5 mM Na3VO4) were used for enzymatic assays and
co-IPs. Denaturing conditions (radio-IP assay buffer: 50 mM
Tris/HCl [pH 7.4], 150mMNaCl, 1 mMEDTA, 0.1% [wt/vol] SDS,
0.5% [wt/vol] sodium deoxycholate, 1% [vol/vol] NP-40, 10 mM
NaF, and 0.5 mM Na3VO4) were needed for IP of chromatin
proteins. In general, 25 µl beads per sample were equilibrated
with IP buffer and mixed with up to 1 µg of antibody. Super-
natants from lysis under native or denaturing conditions were
added and samples were rotated at 4°C. Up to 10% of the su-
pernatants were collected as input controls. After 3–4 h, beads
were washed ﬁve times with 1 ml IP buffer at 4°C for 10 min.
Bound proteins were subjected for further use or eluted by ad-
dition of 30 µl 1.5× SDS sample buffer followed by incubation at
95°C for 5 min. Samples were centrifuged at 16,000 g for 2 min,
and supernatants were analyzed by SDS-PAGE and Western
blotting.
Peptide pulldown assays
Peptide pulldown assays were performedwith native cell lysates
and biotinylated peptides. 2.5 µg peptides were dissolved in
100 µl PBS and incubated with Strep-Tactin magnetic beads
(Qiagen) at 4°C for 1 h. Unbound peptides were removed by
washing three times with PBS. Beads were added to cell lysates
and rotated at 4°C for 3 h. Beads were washed ﬁve times with
cold PBS, and proteins were eluted with 30 µl 2× LDS sample
buffer and incubated at 95°C for 5 min. Eluates were centrifuged
at 16,000 g for 2 min, and supernatants were collected for fur-
ther analysis.
ELISA
ELISA was performed with NeutrAvidin coated 96-well plates
(Pierce) and biotinylated peptides. Pre-blocked plates were
washed three times with ELISA wash buffer (TBS-T with 0.1%
[wt/vol] BSA). Peptides were dissolved in PBS, and 2.5 µg pep-
tide was added per well. Peptide binding was achieved at room
temperature after 2 h. Unbound peptides were removed by
washing three times with ELISA wash buffer, and decreasing
dilutions of test antibodies were transferred to the wells for
20 min. Wells were washed three times, and secondary HRP-
conjugated antibodies were added for 20 min. Wells were
washed again three times, and substrate solution (110 mM so-
dium acetate, pH 5.5; 0.1% [vol/vol] H2O2; and 0.1 µg/ml TMB)
was added for 5 min. Reaction was stopped by addition of one
volume stop solution (10% [vol/vol] H2SO4), and antibody
binding was quantiﬁed by emission at 450 nm.
Microscope image acquisition
3D-SIM (for Figs. 1 E; 2, A–C; 3, A and B; and 4, A and C) was
performed with a Zeiss Elyra PS1 microscope ﬁtted with a Plan
Apochromat differential interference contrast (DIC), 63×/1.4 NA
oil lens. Images were acquired at room temperature using an EM
charge-coupled device Andor iXon DU 885 camera, using ﬁve
rotations and ﬁve translations of the illumination pattern. High-
power diode lasers of 405-, 488-, 561-, and 642-nm wavelengths
were used in combination with BP 420–480, BP 495–575, BP
570–650, and LP 655 emission ﬁlters, respectively. Raw images
were reconstructed into high resolution images using Zeiss ZEN
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2012 software. Confocal images for Fig. 4 (B and D) were ac-
quired at room temperature with a Leica TCS SP8X White Light
confocal microscope equipped with a 63×/1.4 NA oil lens and
HyD detector (Leica Microsystems), using a 0.13-µm z-step size
(∼15–30 z planes) and Leica Application Suite X (LAS X) soft-
ware. Representative images were deconvolved using Huygens
Software (Scientiﬁc Volume Imaging b.v.) and shown as maxi-
mum intensity projections. Confocal images for Fig. 7 B, Fig. 9 F,
Fig. 10 A, and Fig. S2 were acquired at room temperature with a
Leica TCS SP2 AOBS microscope using a Plan-Apochromat 63×/
1.4 NA oil lens (Leica Microsystems) and Leica LCS acquisition
software. Samples were illuminated using a diode 405-nm laser,
a HeNe 543-nm laser, and an Argon laser for 488-nm excitation.
Immunoﬂuorescence images for ﬁgure for Fig. 6 D, Fig. 7 A,
Fig. S3 A, and Fig. S5 A were acquired at room temperature
with an Eclipse TE2000-E inverted microscope (Nikon)
equipped with an X-Cite Series 120 ﬂuorescence microscope
light source (EXFO), a T-RCP remote control (Nikon), an
ORCA-spark Digital CMOS camera C11440-36U (Hamamatsu),
and a Nikon Plan-Apochromat 100×/1.4 NA oil lens using NIS
Elements AR 3.00 software (Nikon). The open source image
processing program ImageJ was used for image projection
(maximum intensity) and calculation of scale bars. Brightness
and contrast were adjusted with ImageJ or Adobe Photoshop.
Fluorescence intensities were quantiﬁed with ImageJ and
analyzed using GraphPad Prism.
Real-time quantitative PCR (qPCR)
RNA was extracted with RNeasy Mini kit and QIAshredder
(Qiagen) according to the manufacturer’s instructions. Mes-
senger RNA was converted to cDNA by reverse transcription
using the SuperScript II RT (Thermo Fisher). Relative expres-
sion of target genes was analyzed by real-time qPCR. SYBR green
(Thermo Fisher) was used as a ﬂuorescence reporter for cDNA
levels during ampliﬁcation by PCR. Real-time qPCR was per-
formed in StepOnePlus Real-Time PCR system (Applied Bio-
systems). Every reaction was performed as triplicates and
quantiﬁed with the ΔΔCT-method. Therefore, threshold cycles
(CT) of target genes were normalized to a housekeeping gene
(ACTB). The resulting ΔCT were compared with control samples
and relative mRNA expression was calculated by R = 2−ΔΔCT.
Online supplemental material
Fig. S1 shows results from the characterization of the phospho-
speciﬁc antibodies. Fig. S2 shows the effects of kinase inhibitors
on H2B S6ph. Fig. S3 shows the effects of phosphatase inhibition
on H2B S6ph. Fig. S4 relates to Fig. 8 and displays further details
for the antibody injection experiments. Fig. S5 shows the lo-
calization of 14-3-3 proteins, the inducible expression of GFP-
SET, and in vitro kinase assays with recombinant CDK com-
plexes and histone octamers as substrates. Table S1 shows the
results from the siRNA kinase screen. Table S2 displays MS
results for the identiﬁcation of phosphorylation-dependent H2B
(1–20) interactors. Table S3 lists reagents and materials. Video
1 shows the mitotic effects caused by the injection of IgG control
antibodies. Video 2 shows the mitotic effects caused by the in-
jection of anti-H2B S6ph antibodies.
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